New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.
February 03, 2010
UCSF Chancellor Susan Desmond-Hellmann outlines a vision for faster development of better, cheaper drugs to fight cancer.
February 02, 2010
The UCSF Resource Allocation Program (RAP) is accepting applications for the spring 2010 funding cycle.